Global /China /Healthcare /Drug Manufacturers - General /300181
chevron_leftBack
Zhejiang Jolly Pharmaceutical Co.,LTD logo

Zhejiang Jolly Pharmaceutical Co.,LTD

300181
SHE: 300181 Delayed
15.21CNY -1.4%
2.25 USD
As of 22 June 2026, Zhejiang Jolly Pharmaceutical Co.,LTD has a market cap of $1.56B USD, ranking #8263 globally and #2131 in China. It ranks #692 in the Healthcare sector, and #267 in the Drug Manufacturers - General industry.
Global Rank
8263
Country Rank
2131
Sector Rank
692
Industry Rank
267
Key Stats
Market Cap
$1.56BUSD
10.54B CNY
Enterprise Value
$1.57BUSD
10.66B CNY
Revenue (TTM)
$460.02MUSD
3.11B CNY
EBITDA (TTM)
$133.0MUSD
900.36M CNY
Net Income (TTM)
$96.07MUSD
650.37M CNY
EBITDA Margin
29%
Profit Margin
21%
PE Ratio
16.2
PS Ratio
3.4
PB Ratio
3.0
EV/EBITDA
11.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Tao Wang open_in_new
Employees
2,125
Founded
1995
Website
zuoli.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.4% -7.9% -1.9% -11% -12% -4%

News

Loading...

Markets

Exchange Ticker Price
Shenzhen Stock Exchange
MIC: XSHE
PRIMARY
300181
浙江佐力药业股份有限公司 Class A
ISIN: CNE100001096
Shares Out.:
693.217M1 Shares Float: 542.469M2
TV:
SA:
YF:
GF:
BA:
MS:
15.21 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Jolly Pharmaceutical Co.,LTD

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, it offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, the company provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, it offers materials, such as cephalosporin sinensis, fermented cordyceps, and Wuling powders. The company also invests and participates in the medical services of Deqing No.3 People’s Hospital. Zhejiang Jolly Pharmaceutical Co.,LTD was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co.,LTD in 1998. The company was founded in 1995 and is based in Huzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)
Name
Market Cap diff.
PE
$53.9B
364.89B CNY
3K%
44.9
603259
$49.69B
336.36B CNY
3K%
17.2
$28.52B
223.48B HKD
2K%
35.7
$18.8B
147.32B HKD
1K%
162.3
$16.53B
111.89B CNY
961%
-
9926
$16.01B
125.46B HKD
928%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
49K%
38.1
JNJ
$547.28B
35K%
26.4
ABBV
$360.63B
23K%
97.4
$318.49B
256.25B CHF
20K%
19.9
AZN
$286.12B
215.59B GBP
18K%
27.6
MRK
$274.03B
17K%
15.1
chevron_leftBack